Stark Tx is changing the way the world treats chronic diseases with gene therapy
Raised to Date: $18,262
Aggregate Commitments $
Weekly Commitments $
Stark Therapeutics, with a valuation cap of $8 million, is raising crowdfunding on Wefunder. The company uses gene therapy to treat chronic diseases. It is currently working on gene therapy for type II diabetes and a vaccine for COVID-19 targeting the nucleocapsid protein. Stark Therapeutics was founded by Anthony Stark in 2018 and has raised over $55,000 since its inception. The company’s crowdfunding round has a minimum target of $50,000 and a maximum target of $1,070,000, and the funds will be used for regulatory consulting, diabetes proof of concept study, vaccine viral challenge study, vaccine manufacturing, FDA consulting, and hiring production specialist. Stark Therapeutics is in the preclinical stage to evaluate the vaccine for COVID-19 and is prepared to scale to 100,000 doses in a few weeks after trial results.
Ratings Platform - Beta Trial
Our new ratings and analytics platform is currently in Beta. To gain access to the Beta platform features, upgrade to a Pro paid account and accept the Beta terms on any page.For a limited time, use coupon code "TRYMERLIN20" for a free 20 day trial of Kingscrowd Pro and Merlin Beta. Your paid subscription will activate at the end of 20 days. Cancel anytime.